NO305029B1 - Bicykliske tetrahydropyrazolopyridiner - Google Patents

Bicykliske tetrahydropyrazolopyridiner

Info

Publication number
NO305029B1
NO305029B1 NO960056A NO960056A NO305029B1 NO 305029 B1 NO305029 B1 NO 305029B1 NO 960056 A NO960056 A NO 960056A NO 960056 A NO960056 A NO 960056A NO 305029 B1 NO305029 B1 NO 305029B1
Authority
NO
Norway
Prior art keywords
tetrahydropyrazolopyridines
bicyclic
bicyclic tetrahydropyrazolopyridines
Prior art date
Application number
NO960056A
Other languages
English (en)
Norwegian (no)
Other versions
NO960056D0 (no
NO960056L (no
Inventor
Allen Jacob Duplantier
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO960056D0 publication Critical patent/NO960056D0/no
Publication of NO960056L publication Critical patent/NO960056L/no
Publication of NO305029B1 publication Critical patent/NO305029B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO960056A 1993-07-06 1996-01-05 Bicykliske tetrahydropyrazolopyridiner NO305029B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8829293A 1993-07-06 1993-07-06
PCT/IB1994/000156 WO1995001980A1 (en) 1993-07-06 1994-06-16 Bicyclic tetrahydro pyrazolopyridines

Publications (3)

Publication Number Publication Date
NO960056D0 NO960056D0 (no) 1996-01-05
NO960056L NO960056L (no) 1996-01-05
NO305029B1 true NO305029B1 (no) 1999-03-22

Family

ID=22210524

Family Applications (1)

Application Number Title Priority Date Filing Date
NO960056A NO305029B1 (no) 1993-07-06 1996-01-05 Bicykliske tetrahydropyrazolopyridiner

Country Status (20)

Country Link
EP (1) EP0707585A1 (enrdf_load_html_response)
JP (1) JP2944048B2 (enrdf_load_html_response)
KR (1) KR100228949B1 (enrdf_load_html_response)
CN (1) CN1048015C (enrdf_load_html_response)
AU (1) AU695301B2 (enrdf_load_html_response)
BR (1) BR9406946A (enrdf_load_html_response)
CA (1) CA2166721C (enrdf_load_html_response)
CZ (1) CZ3696A3 (enrdf_load_html_response)
EG (1) EG20513A (enrdf_load_html_response)
FI (1) FI943208A7 (enrdf_load_html_response)
HU (1) HUT74170A (enrdf_load_html_response)
IL (1) IL110175A (enrdf_load_html_response)
MX (1) MX9405132A (enrdf_load_html_response)
NO (1) NO305029B1 (enrdf_load_html_response)
NZ (1) NZ266525A (enrdf_load_html_response)
PL (1) PL312426A1 (enrdf_load_html_response)
RU (1) RU2131876C1 (enrdf_load_html_response)
TW (1) TW316904B (enrdf_load_html_response)
WO (1) WO1995001980A1 (enrdf_load_html_response)
ZA (1) ZA944844B (enrdf_load_html_response)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09511758A (ja) * 1994-10-20 1997-11-25 フアイザー・インコーポレイテツド 二環式テトラヒドロピラゾロピリジンおよび医薬としてのその使用
WO1996039408A1 (en) * 1995-06-06 1996-12-12 Pfizer Inc. TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO[3,4-c]-1,2,4-TRIAZOLO[4,3-α]PYRIDINES
AP932A (en) * 1996-08-26 2001-02-02 Pfizer Tricyclic 5,6-dihydro-9H-pyrazolo (3,4c)-1,2,4,-triazolo (4,3-a) pyridines.
AU724549B2 (en) * 1996-09-04 2000-09-28 Pfizer Inc. Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF)
WO2001013953A2 (en) 1999-08-21 2001-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh Synergistic combination of pde inhibitors and beta 2 adrenoceptor agonist
ES2230719T3 (es) * 1997-09-26 2005-05-01 Zentaris Gmbh Compuestos basados en azabencimidazol para modular una funcion de proteina-quinasa de serina/treonina.
AU759711B2 (en) * 1998-12-23 2003-04-17 Bristol-Myers Squibb Holdings Ireland Unlimited Company Nitrogen containing heterobicycles as factor XA inhibitors
US6858616B2 (en) 1998-12-23 2005-02-22 Bristol-Myers Squibb Pharma Company Nitrogen containing heterobicycles as factor Xa inhibitors
US6326495B2 (en) 1999-04-30 2001-12-04 Pfizer Inc. Process for preparing 8-cyclopentyl-6-ethyl-3-[substituted]-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacenes and intermediates useful therein
TWI243055B (en) * 2000-04-13 2005-11-11 Nippon Zoki Pharmaceutical Co Pharmaceutical composition for use in treatment of dermatitis
HU229824B1 (en) * 2000-08-10 2014-08-28 Pfizer Italia Srl Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
MXPA03001422A (es) * 2000-08-14 2004-01-26 Johnson & Johnson Pirazoles substituidos.
US6960595B2 (en) * 2001-03-23 2005-11-01 Bristol-Myers Squibb Pharma Company 5-6 to 5-7 Heterobicycles as factor Xa inhibitors
WO2002085356A1 (en) 2001-04-18 2002-10-31 Bristol-Myers Squibb Company 1, 4, 5, 6-tetrahydropyrazolo-[3, 4-c]-pyrid in-7-ones as factor xa inhibitors
US6706730B2 (en) 2001-04-18 2004-03-16 Bristol-Myers Squibb Pharma Company 1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-ones as factor Xa inhibitors
EP1396493A4 (en) * 2001-04-26 2005-08-03 Ajinomoto Kk HETEROCYCLIC COMPOUNDS
KR100908176B1 (ko) * 2001-09-21 2009-07-16 브리스톨-마이어스스퀴브컴파니 인자 Ｘａ 억제제로서의 락탐-함유 화합물 및 그의 유도체
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP1611131B1 (en) 2003-02-27 2010-09-15 Palau Pharma, S.A. Pyrazolopyridine derivates
US7135469B2 (en) * 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
EP1624893A2 (en) 2003-04-01 2006-02-15 Applied Research Systems ARS Holding N.V. Inhibitors of phosphodiesterases in infertility
US7145012B2 (en) 2003-04-23 2006-12-05 Pfizer Inc. Cannabinoid receptor ligands and uses thereof
TW200618800A (en) * 2004-08-03 2006-06-16 Uriach Y Compania S A J Heterocyclic compounds
DE102005031580A1 (de) * 2005-07-06 2007-01-11 Aicuris Gmbh & Co. Kg Substituierte Sulfolanylpyrazole und ihre Verwendung
PE20081889A1 (es) * 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN101772513B (zh) 2007-06-04 2013-11-13 协同医药品公司 有效用于胃肠功能紊乱、炎症、癌症和其他疾病治疗的鸟苷酸环化酶激动剂
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
EP2958577A2 (en) 2013-02-25 2015-12-30 Synergy Pharmaceuticals Inc. Guanylate cyclase receptor agonists for use in colonic cleansing
US9486494B2 (en) 2013-03-15 2016-11-08 Synergy Pharmaceuticals, Inc. Compositions useful for the treatment of gastrointestinal disorders
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EA201592263A1 (ru) 2013-06-05 2016-05-31 Синерджи Фармасьютикалз, Инк. Ультрачистые агонисты гуанилатциклазы c, способ их получения и использования
IL280864B2 (en) 2013-08-09 2024-03-01 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
CN110357888A (zh) * 2018-04-09 2019-10-22 南京药捷安康生物科技有限公司 杂环磷酸二酯酶抑制剂及其用途
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340269A (en) * 1964-09-08 1967-09-05 Ciba Geigy Corp 1-substituted 4-acyl-2, 3-dioxo-piperidine
FR1463883A (fr) * 1964-09-08 1966-07-22 Ciba Geigy Procédé de préparation de triaza-composés bicycliques
US3365459A (en) * 1964-09-08 1968-01-23 Ciba Geigy Corp Certain tetrahydro pyrazolo-pyridine and pyrazolo-piperidine derivatives
HU183325B (en) * 1981-02-11 1984-04-28 Richter Gedeon Vegyeszet Process for preparing new apovincaminol-3',4',5'-trimethoxy-benzoates substituted with a nitro group
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
FR2525602A1 (fr) * 1982-04-21 1983-10-28 Synthelabo Imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
US4668686A (en) * 1985-04-25 1987-05-26 Bristol-Myers Company Imidazoquinoline antithrombrogenic cardiotonic agents
US5356897A (en) * 1991-09-09 1994-10-18 Fujisawa Pharmaceutical Co., Ltd. 3-(heteroaryl)-pyrazololi[1,5-a]pyrimidines

Also Published As

Publication number Publication date
PL312426A1 (en) 1996-04-29
IL110175A0 (en) 1994-10-07
HU9503934D0 (en) 1996-03-28
FI943208A0 (fi) 1994-07-05
AU695301B2 (en) 1998-08-13
IL110175A (en) 2000-01-31
NO960056D0 (no) 1996-01-05
CN1048015C (zh) 2000-01-05
CA2166721C (en) 1999-07-27
JPH08507084A (ja) 1996-07-30
CN1129940A (zh) 1996-08-28
FI943208L (fi) 1995-01-07
NZ266525A (en) 1997-10-24
FI943208A7 (fi) 1995-01-07
CA2166721A1 (en) 1995-01-19
NO960056L (no) 1996-01-05
AU6805794A (en) 1995-02-06
KR100228949B1 (ko) 1999-11-01
EG20513A (en) 1999-06-30
CZ3696A3 (en) 1997-06-11
RU2131876C1 (ru) 1999-06-20
JP2944048B2 (ja) 1999-08-30
MX9405132A (es) 1995-01-31
HUT74170A (en) 1996-11-28
KR960703852A (ko) 1996-08-31
WO1995001980A1 (en) 1995-01-19
BR9406946A (pt) 1996-08-06
TW316904B (enrdf_load_html_response) 1997-10-01
ZA944844B (en) 1996-01-05
EP0707585A1 (en) 1996-04-24

Similar Documents

Publication Publication Date Title
FI943208A7 (fi) Bisyklisiä tetrahydropyratsolopyridiinejä
NO922112D0 (no) Bicykliske rapamyciner
FI941580L (fi) Bisyklisiä ansamysiinejä
BR9405832A (pt) Imidazoazinas
NO962456D0 (no) Anti-begroningsmiddel
FI954991A0 (fi) Bisyklisiä tetrahydropyrazolopyridiinejä
DE69413933D1 (de) Antitussiva
ATA146094A (de) Windsichter
NO961057L (no) Hjörnesammenföyningsmontasje
ATA179094A (de) Kettenschloss
ATA194593A (de) Sportschuh
ATA108193A (de) Beschlag
FI934864L (fi) Bicykliska karbamater
KR950005495U (ko) 조립식 가구
KR940025134U (ko) 관이음쇠
KR940025137U (ko) 관이음쇠
KR940022970U (ko) 조립식 가구
FI1103U1 (fi) Planflissaoll
ATE144907T1 (de) Rollbrett
FI1052U1 (fi) Parkeringsmaetare
BR9304875A (pt) Varitorque
BR9304461A (pt) Tele-loto
ATA38493A (de) Violon-cello
FI934357A0 (fi) Belaeggning
FI932820A0 (fi) Sadelstaellning